Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Harrow Health
company
About
Harrow Health is an eye health pharmaceutical company.
- Nashville,Tennessee,United States
- 101 - 250
- https://www.harrowinc.com/
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Stock Symbol
- nasdaq:HROW
- Legal Name
- Harrow Health, Inc.
- Also Known As
- Imprimis Pharmaceuticals, Inc.,TRANSDEL PHARMACEUTICALS INC,Bywater Resources, Inc
Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website,www.harrowinc.com.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
7
$123.74M
Harrow Health has raised a total of
$123.74M
in funding over 2 rounds. Their latest funding was raised on
Dec 14, 2022 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 14, 2022 | Post-IPO Equity | $25M | — | — | — | Detail |
| Apr 14, 2021 | Post-IPO Debt | $50M | — | — | — | Detail |
| Jul 20, 2017 | Post-IPO Debt | $16M | 1 |
|
— | Detail |
| Dec 19, 2016 | Post-IPO Equity | $9.80M | — | — | — | Detail |
| May 12, 2015 | Post-IPO Debt | $15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Harrow Health is funded by 2 investors.
SWK Funding
and Life Sciences Alternative Funding
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Debt |
Life Sciences Alternative Funding
|
— | Post-IPO Debt |
Employee Profiles
Number of Employee Profiles
3
Harrow Health has 3 current employee profiles, including
Executive Andrew R. Boll
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
